CD40LG and autoimmune disease: By employing anti-IgM-crosslinked BCR activation on Ramos cells to mimic B cell hyperactivation, this serves as a platform for studying potential targets with therapeutic potential for treating autoimmune diseases (45, 50, 62, 90–92).